Glycemic and metabolic markers: Trial disclosures describe improvements in glycemic control and cardiometabolic measures alongside weight loss, with cardiovascular outcomes still under study in REDEFINE 3 [8]
In previous studies, human keratinocytes, human epidermis model and human reconstructed skin model human reconstructed skin model were used for testing the response of sodium lauryl sulfate
QLG2-CT-2002-01254), NIH Grant DK U01-066134, The Swedish Foundation for Strategic Research (SSF
What this means for clinical research: mRNA trials are increasingly designed with contingency planning around funding continuity, regulatory signaling, and public-policy exposure not just clinical endpoints
Methods: Prospective single-centre study of 108 patients presenting with acute, severe proximal LVO with a complete neuroimaging study (CT at baseline and follow-up MRI) and blood tests including serum ALCAM measured at 24 and 48 +/- 12 hours